NCT05413057View on ClinicalTrials.gov

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

RecruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Hypertension,Essential
Trial Locations (1)

Unknown

RECRUITING

Seoul National University Bundang Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY